Correlation Between Telix Pharmaceuticals and Opus Genetics,

Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telix Pharmaceuticals Limited and Opus Genetics,, you can compare the effects of market volatilities on Telix Pharmaceuticals and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Opus Genetics,.

Diversification Opportunities for Telix Pharmaceuticals and Opus Genetics,

0.14

Correlation Coefficient

Telix Pharmaceuticals  Opus Genetics,

Average diversification

The 3 months correlation between Telix and Opus is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Opus Genetics, go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Opus Genetics,

Considering the 90-day investment horizon Telix Pharmaceuticals Limited is expected to generate 0.37 times more return on investment than Opus Genetics,. However, Telix Pharmaceuticals Limited is 2.72 times less risky than Opus Genetics,. It trades about 0.1 of its potential returns per unit of risk. Opus Genetics, is currently generating about -0.06 per unit of risk. If you would invest  1,515  in Telix Pharmaceuticals Limited on September 24, 2024 and sell it today you would earn a total of  67.00  from holding Telix Pharmaceuticals Limited or generate 4.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Telix Pharmaceuticals Limited  vs.  Opus Genetics,

Telix Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Telix Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Opus Genetics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Telix Pharmaceuticals and Opus Genetics,

The main advantage of trading using opposite Telix Pharmaceuticals and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.

The idea behind Telix Pharmaceuticals Limited and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.